These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8814343)

  • 21. Aging modifies the expression of hepatic microsomal cytochromes P-450 after pretreatment of rats with beta-naphthoflavone or phenobarbital.
    Sun JQ; Lau PP; Strobel HW
    Exp Gerontol; 1986; 21(2):65-73. PubMed ID: 3758228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiles of ethanol-induced microsomal alkoxyresorufin (alkoxyphenoxazone) O-dealkylation: comparison with phenobarbital- and Aroclor 1254-induced systems.
    Winston GW; Narayan S; Bounds PL
    Alcohol Alcohol; 1990; 25(6):667-72. PubMed ID: 2085350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone.
    Small DS; McNamara PJ
    Drug Metab Dispos; 1995 Apr; 23(4):465-72. PubMed ID: 7600913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity.
    Verschoyle RD; Carthew P; Wolf CR; Dinsdale D
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):208-13. PubMed ID: 8212003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo.
    Jenner AM; Timbrell JA
    Arch Toxicol; 1994; 68(6):349-57. PubMed ID: 8092926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed-function oxidase system induction and propylene hepatotoxicity.
    Osimitz TG; Conolly RB
    J Toxicol Environ Health; 1985; 15(1):39-49. PubMed ID: 2984438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological and enzymatic comparison of hepatic cytochrome P-450 fractions from phenobarbital-, 3-methylcholanthrene-, beta-naphthoflavone- and 2,3,7,8- tetrachlorodibenzo-p-dioxin-treated rats.
    le Provost E; Cresteil T; Columelli S; Leroux JP
    Biochem Pharmacol; 1983 Jun; 32(11):1673-82. PubMed ID: 6870906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activation of isophosphamide and trophosphamide to metabolites mutagenic for bacteria.
    Della Morte R; Belisario MA; Remondelli P; Mugnoz B; Staiano N
    Toxicol Lett; 1986 Jun; 31(3):183-8. PubMed ID: 3523833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol-inducible cytochrome P-450 is more susceptible to in vitro carbon tetrachloride-mediated destruction than phenobarbital-inducible and beta-naphthoflavone-inducible cytochromes P-450.
    Gadeholt G
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):216-23. PubMed ID: 6334430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of aromatic oxidation of estradiol-17 beta in maternal hepatic, fetal hepatic and placental tissues: comparative effects of a series of inducing agents.
    Namkung MJ; Porubek DJ; Nelson SD; Juchau MR
    J Steroid Biochem; 1985 Apr; 22(4):563-7. PubMed ID: 3999749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of inducer pretreatment on liver function and morphology in the mountain vole Microtus montanus.
    Hincks JR; Brindley WA
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(2):343-7. PubMed ID: 2882929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P-450- and glutathione-associated enzyme activities in freshly isolated enriched lung cell fractions from beta-naphthoflavone-treated male F344 rats.
    Lacy SA; Mangum JB; Everitt JI
    Toxicology; 1992; 73(2):147-60. PubMed ID: 1609425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of varying inducer type and dose on hepatic monooxygenase activities in the mountain vole Microtus montanus.
    Hincks JR; Brindley WA
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(2):385-9. PubMed ID: 2879697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of group-1 and group-2 UDP-glucuronosyltransferase in microsomes from the livers of C57 Bl/6 mice.
    Batt AM; Martin N; Siest G
    Toxicol Lett; 1981 Dec; 9(4):355-60. PubMed ID: 6800071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered induction response of hepatic cytochrome P-450 to phenobarbital, 3-methylcholanthrene, and beta-naphthoflavone in organotin-treated animals.
    Rosenberg DW; Sardana MK; Kappas A
    Biochem Pharmacol; 1985 Apr; 34(7):997-1005. PubMed ID: 3986002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices.
    Lake BG; Charzat C; Tredger JM; Renwick AB; Beamand JA; Price RJ
    Xenobiotica; 1996 Mar; 26(3):297-306. PubMed ID: 8730921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays.
    Elliott BM; Combes RD; Elcombe CR; Gatehouse DG; Gibson GG; Mackay JM; Wolf RC
    Mutagenesis; 1992 May; 7(3):175-7. PubMed ID: 1602970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific induction of the carcinogen inducible cytochrome P450 isoform, P450IAI, in colonic epithelium.
    Rosenberg DW
    Arch Biochem Biophys; 1991 Jan; 284(1):223-6. PubMed ID: 1989500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in induction by xenobiotics in murine tissues and the Hepa1c1c7 cell line of mRNAs encoding glutathione transferase, quinone reductase, and CYP1A P450s.
    Sisk SC; Pearson WR
    Pharmacogenetics; 1993 Aug; 3(4):167-81. PubMed ID: 8220436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.